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Protein stabilityProtein kinase CK2 is a pleiotropic enzyme, which is implicated in the regulation of numerous biological pro-
cesses. It seems to regulate the various functions by binding to other proteins and by phosphorylation of
many different substrates. Here, we identiﬁed the activating transcription factor 4 (ATF4), an essential com-
ponent of the ER stress signaling, as a new binding partner and a new substrate of CK2 in vitro and in vivo.
Biﬂuorescence complementation analysis (BiFC) revealed that CK2α and ATF4 associate in the nucleus. By
using mutants of ATF4 we identiﬁed serine 215 as the main CK2 phosphorylation site. The ATF4 S215A
mutant turned out to be more stable than the wild-type form. We further noticed that an inhibition of CK2
caused an increased transcription of the ATF4 gene. Analyses of the transcription factor activity revealed an
impaired activity of the CK2 phosphorylation mutant of ATF4. Thus, we show that (i) ATF4 is a binding part-
ner of CK2α (ii) ATF4 is a substrate of CK2, (iii) the phosphorylation of ATF4 by CK2 inﬂuences the stability of
ATF4, (iv) the transcription of ATF4 is regulated by CK2 and (v) the transcription factor activity of ATF4 is reg-
ulated by the CK2 phosphorylation of ATF4. Thus, CK2 plays an essential role in the regulation of the ER-stress
induced signaling pathway.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Protein kinase CK2, formerly known as casein kinase 2 is a ubiqui-
tously expressed pleiotropic serine and threonine kinase, which is
absolutely essential for life of eukaryotes. In many organisms protein
kinase CK2 is a heterotetramer composed of two catalytic α- or
α′-subunits and two non-catalytic β-subunits [1]. CK2 is known to
phosphorylate more than 300 different substrates including many pro-
teins involved in transcription. In addition to the holoenzyme there is
increasing evidence for CK2 subunits either in free form or associated
with other proteins [2–5]. Substrates can be phosphorylated by the cat-
alytic subunits alone or by the holoenzyme. By using a yeast two-hybrid
screen with CK2α as a bait, we recently identiﬁed the splicing factor
hPrp3p, the motor neuron protein KIF5C, the transcription factor
Pdx-1 and the transition nuclear protein TNP-1 as new binding partners
of CK2 [6–11]. With the exception of TNP-1, all other new binding part-
ners also served as substrates for CK2. Binding partners of CK2 were
found tobe associatedwithin the plasmamembrane, and are implicated
in the regulation of gene expression by targeting intracellular signaling
cascades, DNA replication, transcription or the translation machinery,
cell cycle regulatory proteins or guardian angels maintaining cellular
integrity or apoptosis [12]. Here, we identiﬁed the transcription factor
ATF4, a central molecule in the ER stress signaling pathway, as a new
binding partner and as a new substrate for CK2.x: +49 6841 162 6027.
ntenarh).
rights reserved.The activating transcription factor 4 (ATF4) also known as CREB-2
was ﬁrst identiﬁed as a transcription factor that can negatively regu-
late transcription from the cAMP responsive element [13]. ATF4 is a
member of the ATF family of basic leucine zipper transcription factors,
which are implicated in stress responses [14,15], development [16]
and learning memory [17]. ATF4 can be transcriptionally [18] and
translationally [15,19] regulated. In response to unfolded protein
response in the endoplasmic reticulum (ER) the PERK kinase phosphor-
ylates the eukaryotic initiation factor eIF2α thereby down-regulating
global translation. However, a group of stress-responsive mRNAs
including ATF4 is translated more efﬁciently when eIF2α is phosphory-
lated. ATF4 is expressed only at low concentrations, but becomes rapid-
ly induced under stress conditions. ATF4 binds to promoter regions of
genes whose products are implicated in adaptation, redox control or
depending on the extent of ER stress can trigger apoptosis. Forced
expression of ATF4 was sufﬁcient to promote cell death [20]. In the
ER-stress pathway there are two proteins, CHOP/gadd153 and Nrf2
[21,22] whose activities are regulated by CK2 phosphorylation and
whose transcription is regulated by ATF4. There is increasing evidence
that ATF4 is also regulated by phosphorylation [23,24]. Therefore in the
present study we analyzed whether ATF4 might be a substrate for CK2
and how CK2 phosphorylationmight regulate ATF4 properties and func-
tions. By subjecting ATF4 to an in silico phosphorylation,we identiﬁed 12
putative CK2 phosphorylation sites. By in vitro and in vivo assays, we
identiﬁed ATF4 as a new substrate for CK2. Using deletion as well as
point mutants of ATF4, we identiﬁed serine 215 as the main CK2 phos-
phorylation site. Finally, it turned out that CK2 phosphorylation at serine
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ATF4.
2. Material and methods
2.1. Chemicals and biological reagents
DNA modifying enzymes were purchased from Fermentas (Thermo
scientiﬁc, St. Leon-Rot, Germany). Tissue culturemedia were purchased
from GIBCO. The fetal calf serum (FCS) was from PAA (Pasching,
Austria) and γ[32P]ATP from Hartmann Analytic (Braunschweig,
Germany). Cycloheximide (CHX) was purchased from Roth (Karlsruhe,
Germany), MG132 and thapsigargin were purchased from ENZO life
sciences (Lörrach, Germany). 4,5,6,7-Tetrabromobenzotriazole (TBB,
VWR, Darmstadt) [25] and quinalizarin (Labotest OHG, Niederschöna)
[26], both speciﬁc CK2 inhibitors, were dissolved in dimethyl
sulfoxide (DMSO) to 10 mM stock solutions. We used TBB and
quinalizarin in a concentration of 50 μM over a period of 24 h. 3,3′,5,5′
Tetramethylbenzidine (TMB) was from Sigma-Aldrich (München,
Germany), 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI) was
from Roche (Mannheim, Germany).
2.2. Cell lines
HeLa cells (ATCC; CCL-2) were cultured in Dulbecco's modiﬁed
Eagle's medium containing 10% fetal calf serum (FCS) and 1% gluta-
mine. Cells were cultured at 37 °C and 5% CO2 in a humidiﬁed atmo-
sphere in an incubator.
2.3. Plasmid DNA constructs
Deletionmutants of ATF4 were created by PCR and inserted into the
plasmid pGEX-4T-1 in frame with the GST-coding sequence. Point
mutations were generated by overlapping extension PCR and the
mutated DNA was cloned into the plasmid pGEX-4T-1 and p3XFLAG-
CMV7.1 (Sigma-Aldrich, München, Germany). The integrity of the
DNA constructs was veriﬁed by sequencing. The ATF4 5′UTR and
AUG-Luc (No. 21850) were purchased from Addgene (Cambridge,
USA). The 2xAARE-Luc was kindly provided by Dr. A. Bruhat [27]. The
5′UTR ATF3-Luc was a kind gift from G. Thiel (Homburg, Germany)
[28,29].
For the BiFC analysis (bimolecular ﬂuorescent complementation),
pEYFPc1 vectors containing the full-length CK2α and the full-length
CK2βwere a kind gift of O. Filhol (Grenoble, France) [30]. To generate
an YN- and YC-ATF4 we digested ATF4 wild-type, which was cloned
into p3XFLAG-CMV7.1 with EcoRI and BamHI. Subsequently the
fragment was cloned into pEYFPc1, which contains either the
N-terminal fragment of EYFP (AS 1–154) or the C-terminal fragment
(AS 155–238). The dominant-negative mutants CK2α K68M and CK2α′
K69M (generous gift of D. Litchﬁeld, London, Ontario, Canada)were gen-
erated by cloning the cDNA from the corresponding pRC/CMV vectors
into Hind III/BamHI sites of p3xFlag/CMV-7.1 [31]. Constructs generated
by cloning were checked by DNA sequencing.
2.4. Antibodies
The antibodies eIF2α (# 9722) and phospho-eIF2α (# 9721) were
purchased from New England BioLabs (Frankfurt am Main, Germany).
The anti-ATF4 antibodies (sc200) and (sc22800) and also the anti-
GAPDH antibody were purchased from Santa Cruz Inc. (Heidelberg,
Germany); anti-GST antibody (27–4577) was from Pharmacia Biotech
(Freiburg, Germany); anti-FLAG M2 (F1804) antibody and the
anti-α-tubulin (T9026) antibody were purchased from Sigma-Aldrich
(München, Germany); anti-GFP antibody, which recognizes only
full-length YFP, was from Abcam (Cambridge, UK). The antibodies
anti-CK2α antibody #26, anti-CK2β antibody #32, the monoclonalantibodies 1A5 (anti-CK2α) and 6D5 (anti-CK2β) were previously
described [32]. Goat anti-mouse IgG (No. 115-035-146) and goat
anti-rabbit IgG (No. 111-035-144) were from Dianova (Hamburg,
Germany), Alexa Fluor546 goat anti-mouse IgG and Alexa Fluor488
goat anti-rabbit IgGwere fromMolecular Probes (Invitrogen, Darmstadt,
Germany).2.5. Transient transfection and luciferase assay
24 h before transfection with Turbofect® (Fermentas, Thermo
scientiﬁc, St. Leon-Rot, Germany), HeLa cells were seeded on a 10 cm
cell culture plate (for co-immunoprecipitation) in a total volume of
5 ml/plate of DMEM plus 10% FCS and 1% glutamine. 24 h later cells
were transfected with 5 μg DNA by using Turbofect®. For a 6-well
plate (CHX and MG132 experiments), HeLa cells were seeded in a
total volume of 3 ml/well of DMEM supplemented with 10% FCS and
1% glutamine and 24 h later transfected using Turbofect® with 4 μg
DNA. For a 24-well plate (reporter assay), HeLa cells were seeded in a
total volume of 1 ml/well of DMEM plus 10% FCS and 1% glutamine
and 24 h later transfected using Turbofect® with 1 μg DNA. To normal-
ize the experimental variations such as differences in transfection efﬁ-
ciencies we calculated the relative intensities of FLAG tagged protein
amounts ﬁrst in relation to GAPDH and then in relation to the luciferase
activity.2.6. Extraction of proteins
For Western blot analysis, HeLa cells were lysed with RIPA buffer
(50 mM Tris/HCl, pH 8.0, 150 mM NaCl, 0.5% sodium desoxycholate,
1% Triton X-100, 0.1% sodium dodecylsulfate (SDS)), supplemented
with complete® EDTA free (Roche Diagnostics, Mannheim, Germany).
After lysis cell debris was removed by centrifugation at 13,000×g. The
protein content was determined with the BioRad reagent dye (BioRad,
München, Germany). Protein extractswere immediately used forWest-
ern blot analysis.2.7. Western blot analyses
Proteins were separated through a 12.5% SDS polyacrylamide gel,
and transferred onto a PVDF membrane. The membrane was blocked
with 5% dry milk in PBS-Tween20 for 1 h and then incubated with the
speciﬁc antibodies which were diluted in PBS-Tween20 containing 1%
dry milk. The membrane was incubated with a peroxidase-coupled
secondary antibody (anti-rabbit 1:30,000 or anti-mouse 1:10,000)
for 1 h. Signals were visualized by the Lumilight system of Roche
Diagnostics (Mannheim, Germany).2.8. Co-immunoprecipitation
HeLa cells were harvested and lysed 24 h post transfection with
RIPA buffer. After lysis cell debris was removed by centrifugation at
13,000×g. The protein content was determined with the BioRad
reagent dye (BioRad, München, Germany). For co-immunoprecipitation
cell lysates were pre-cleared twice with a mixture of protein A agarose
beads andCL 4-B agarose beads over a period of 45 min. The supernatant
was incubated with a combination of the ATF4 speciﬁc rabbit polyclonal
antibodies sc200 and sc-22800 (Santa Cruz Inc. Heidelberg, Germany)
(15 μl of each) for 90 min. Beads were washed twice with PBS, pH 7.4.
Bound proteins were eluted with SDS sample buffer (195 mM Tris/HCl,
pH 6.8, 6% SDS, 15% β-mercaptoethanol, 30% glycerol, and 0.03%
bromophenol blue) and separated on a 12.5% SDS polyacrylamide gel,
transferred to a PVDFmembrane and analyzed byWestern blotwith spe-
ciﬁc antibodies.
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Overnight cultures of Escherichia coli BL21 (DE3) transformed with
GST-fused constructs were diluted 1:10 in LB medium containing
ampicillin. The cultures were grown up to an OD600 nm of 0.6. Protein
expression was induced with isopropyl-1-thio-β-D-galactopyranoside
(IPTG) to a ﬁnal concentration of 1 mM and incubated for 3 h at
37 °C. After centrifugation (5500×g; 10 min; 4 °C), cells were
resuspended in buffer R1 (100 mM Tris/HCl, pH 7.8, 100 mM NaCl,
10 mM MgCl2, and 0.1% (w/v) Tween-20) supplemented with com-
plete® (EDTA free) and 1 mg/ml lysozyme. Cells were lysed by
soniﬁcation (3 times for 1 min) and centrifuged at 13,000×g for
15 min at 4 °C. The supernatants were incubated overnight at 4 °C
with glutathione-agarose 4B (Macherey Nagel, Düren, Germany).
Beads were washed 3 times with buffer R1. The GST-fused constructs
were eluted with buffer R1 containing 20 mM glutathione.
2.10. In vitro phosphorylation with protein kinase CK2
To determine the incorporation of phosphate into the polypeptide
chain of ATF4, GST-ATF4 (0.1 μg) was mixed with 0.6 μg CK2 holoen-
zyme in a volume of 25 μl of kinase buffer (50 mM Tris/HCl, pH 7.5,
150 mMNaCl, 5 mMMgCl2, 50 μMATP, and 1 mMDTT). The reaction
was started by adding 2 μCi γ[32P]ATP and incubated for 5, 15, 30 and
45 min at 37 °C. The reaction was stopped by adding 10 μl of sample
buffer. Finally samples were separated through a 12.5% SDS polyacryl-
amide gel. Phosphorylated proteins were detected by autoradiogra-
phy and the protein bands were densitometrically scanned. The
incorporation rate for the phosphorylation of ATF4 was performed
as described earlier [7]. Brieﬂy ATF4 protein was mixed with protein
kinase CK2 in 20 μl of kinase buffer. The phosphorylation reaction
was started by the addition of γ[32P]ATP. After 30 min at 37 °C the
reaction was stopped by the addition of 10 μl sample buffer. Proteins
were separated in an SDS polyacrylamide gel and visualized by auto-
radiography. The incorporated radioactivity was measured from the
excised bands by scintillation counting.
For the analysis of the phosphorylation of truncated versions of ATF4
recombinant GST-tagged ATF4 fragments (0.2 μg of GST-C1, 0.2 μg of
GST-C2, 0.8 μg of GST-C3, 0.1 μg of GST-N1 and 0.6 μg of GST-N2)
were mixed with equal amounts of CK2α, CK2α′ and CK2 holoenzyme
(0.6 μg) in a volume of 25 μl of kinase buffer (50 mM Tris/HCl, pH 7.5,
150 mM NaCl, 5 mM MgCl2, 50 μM ATP, and 1 mM DTT). To start the
reaction we added 2 μCi γ[32P]ATP and incubated the samples for
30 min at 37 °C. The reaction was stopped by adding 10 μl of sample
buffer. Finally samples were separated through a 12.5% SDS polyacryl-
amide gel. Phosphorylated proteins were detected by autoradiography.
2.11. Determination of the CK2 kinase activity
Cells were lysed and the extracts were used for kinase ﬁlter assays.
The incorporation rate of [32P] phosphate into the CK2-speciﬁc sub-
strate peptide with the sequence RRRDDDSDDD was measured.
20 μl of kinase buffer (50 mM Tris/HCl, pH 7.5, 100 mM NaCl,
10 mM MgCl2, and 1 mM DTT) containing 30 μg of proteins was
mixed with 30 μl CK2 mix (25 mM Tris/HCl, pH 8.5, 150 mM NaCl,
5 mMMgCl2, 50 μM ATP, 1 mM DTT, and 0.19 mM substrate peptide)
containing 10 μCi/500 μl γ[32P]ATP. The mixture was spotted onto a
P81 ion exchange paper. The paper was washed with 85 mM H3PO4
for 3 times. After treatment with ethanol the paper was dried and
the Čerenkov-radiation was determined in a scintillation counter.
2.12. Pulse-labeling with [35S]methionine
HeLa cells were transfected with FLAG-ATF4 or FLAG-ATF4 S215A
for 24 h. Cells were washed three times with methionine-free DMEM
plus 10% FCS and 1% glutamine and for 1 h labeled with 50 μCi of [35S]methionine. The [35S]methionine was removed by washing and the
cells were incubated with DMEM plus 10% FCS and 1% glutamine.
The cells were harvested at indicated times, lysed and FLAG-ATF4
and FLAG-ATF4 S215A were precipitated as described above. The
[35S]methionine labeled proteins were visualized by the Typhoon-
Trio imaging system (GE Healthcare, Munich, Germany).
2.13. GST-pull-down-assay
15 μg of the GST-tagged ATF4 proteins was added to 30 μl of the
GSH sepharose and incubated in 800 μl PBS with 0.1% Tween20 for
1 h. The beads were washed for 3 times in PBS/0.1% Tween-20. The
pull-down reaction was carried out with 15 μg of recombinant CK2
holoenzyme or the individual CK2 subunits. Beads were washed
with PBS/0.1% Tween20 for 4 times and the complex was separated
on a 12.5% SDS polyacrylamide gel and visualized by Coomassie
Blue staining.
2.14. ELISA based binding assay
The ELISA based binding assay was carried out as described by
Hübner et al. [33]. The GST-ATF4 proteins (1 μg/well) or the CK2 holo-
enzyme in 50 mM NaHCO3, pH 9.8, was coated on 96 well polystyrene
microtiter plates (Nunc, Thermo scientiﬁc, Langenselbold) for 16 h at
4 °C. After blocking in 50 mM NaHCO3, pH 9.8, with 5% bovine serum
albumin (BSA) for 90 min at 22 °C, appropriate dilutions of the binding
protein in 50 mMNaHCO3, pH 9.8with 1% bovine serum albumin (BSA)
were added to themicrotiter plates and incubated for 16 h at 4 °C. After
washing with 50 mM NaHCO3, pH 9.8 containing 1% BSA, bound com-
plexes were detected as described for the ligand-Western blot assay
and visualized with 3,3′,5,5′ tetramethylbenzidine (TMB).
2.15. BiFC (bimolecular ﬂuorescent complementation) analysis
HeLa cells were seeded on coverslips and transfected with the
BiFC plasmids for 24 h. After 24 h, cells were shifted to 28 °C for
24 h to promote the ﬂuorophore maturation. Immunostaining of
YFP was performed by indirect immunoﬂuorescence using a GFP
antibody that recognizes only the complete YFP. Cells were ﬁxed in
PBS, pH 7.4 with 4% paraformaldehyde for 10 min, permeabilized in
PBS with 0.5% Triton X-100 for 10 min and pre-incubated in PBS
with 5% BSA for 30 min at room temperature. Cells were incubated
with the GFP antibody for 30 min at 37 °C, washed with PBS and
incubated with Alexa Fluor 546 goat anti-mouse antibody for
30 min at 37 °C. The coverslips were washed and incubated with
DAPI for 30 min at 37 °C before being sealed with mounting media.
2.16. Co-localization experiment
HeLa cells were seeded on coverslips. Immunostaining of ATF4
and CK2 was performed using sc200 and 1A5 antibody, respectively.
Cells were ﬁxed in PBS, pH 7.4 with 2% paraformaldehyde for
10 min, permeabilized in PBS with 0.5% Triton X-100 for 10 min
and pre-incubated in PBS with 5% BSA for 30 min at room tempera-
ture. Cells were incubated with the ATF4 and CK2 antibodies for
30 min at 37 °C, washed with PBS and incubated with Alexa Fluor
488 goat anti-rabbit and Alexa Fluor 546 goat anti-mouse antibody
for 30 min at 37 °C. The coverslips were washed and incubated with
DAPI for 30 min at 37 °C. The coverslips were sealed with mounting
media.
3. Results
CK2 is known to be implicated in the regulation of many different
basic cellular processes including transcription. An increasing number
of transcription factors were identiﬁed as binding partners of protein
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naling cascade leading to growth arrest and eventually apoptosis.
Since also CK2 was shown to be involved in the regulation of mem-
bers of the ER stress pathway, we now wanted to know whether
there might be a direct interaction between ATF4 and CK2. For this
type of experiment we ﬁrst used puriﬁed GST-tagged ATF4 and puri-
ﬁed CK2α2β2 holoenzyme. GST-tagged ATF4 was precipitated with
GSH-sepharose and the associated proteins were analyzed on a
12.5% SDS polyacrylamide gel. As shown in Fig. 1 a GST-ATF4 bound
to the CK2 holoenzyme. Control experiments showed that the CK2
subunits bound neither to GSH-sepharose nor to the GST-tag alone.
In a separate lane we loaded the CK2 holoenzyme as a control. Thus,
these pull-down experiments showed that ATF4 bound to the CK2
holoenzyme in vitro.
Next, we wanted to know whether the interaction between
CK2 and ATF4 also exists in vivo. Therefore, we performed
co-immunoprecipitation experiments in mammalian cells. HeLa
cells were transfected with FLAG-tagged ATF4. Twenty-four hours
after transfection, the cell extract was incubated with protein A
sepharose as a control (C) or with an anti-ATF4 antibody linked
to protein A sepharose (IP). The immunoprecipitate as well as the
supernatant of the immunoprecipitate were analyzed on a 12.5%
SDS polyacrylamide gel followed by a transfer to a PVDF mem-
brane. The membrane was either incubated with an anti-FLAG-tag
antibody to detect ATF4 or with a CK2α- or a CK2β-speciﬁc anti-
body. As shown in Fig. 1 b CK2α was co-immunoprecipitated with
ATF4 (IP). The supernatant of the immunoprecipitate (S) contained
a small amount of ATF4 and considerable amounts of CK2α and
CK2β indicating that the antibody efﬁciently precipitated ATF4
and that only CK2α and no visible amount of CK2β was bound.
To further support the observation above, we performed a
co-immunoprecipitation experiment with endogenous proteins.
To get detectable amounts of endogenous ATF4, HeLa cells were
treated with thapsigargin for 4 h, which induces ER stress [37].
Four hours after treatment with thapsigargin, cells were extracted
and CK2 was immunoprecipitated with the CK2 speciﬁc monoclo-
nal antibody 1A5. Immunoprecipitates were analyzed by Western
blot. As shown in Fig. 1 c CK2α bound to ATF4. As expected CK2α
was also co-precipitated with CK2β in the CK2 holoenzyme (IP).Fig. 1. CK2 interacts with ATF4 in vitro and in vivo. a) GST pull down assay. Bacterially expr
3 h. GST-ATF4 was bound by GSH-sepharose and then bound proteins were separated on a
detected using speciﬁc antibodies. b) Co-immunoprecipitation of endogenous CK2 with FL
incubated with ATF4 speciﬁc antibody sc200. Eluted proteins from immunoprecipitates we
body 6D5. c) Co-immunoprecipitation of endogenous ATF4 with endogenous CK2. HeLa ce
ATF4. Lysates were incubated with CK2α speciﬁc antibody 1A5. Eluted proteins from imm
6D5 and ATF4 with antibody sc200. C, pre-precipitate; IP, immunoprecipitate; S, supernat
the gels.ATF4 was also found in the supernatant (S) indicating that not all
of ATF4 is complexed to CK2. Thus, we conclude from these exper-
iments that ATF4 binds to CK2α not to CK2β.
Having shown that ATF4 bound to CK2, in the next step we
wanted to conﬁrm this interaction by immunoﬂuorescence analysis
and to analyze where in the cell this interaction takes place. HeLa
cells were treated with MG132 for 24 h, a proteasome inhibitor,
which is known to activate ATF4 [38]. Cells were stained with an
antibody directed against ATF4 followed by an Alexa Fluor 488
coupled secondary antibody (green). CK2α was detected with anti-
body 1A5 followed by Alexa Fluor 546 coupled secondary antibody
(red). The overlay shows a yellow staining for co-localized CK2α
and ATF4 (Fig. 2).
To demonstrate a direct interaction between ATF4 and CK2 we
performed a bimolecular ﬂuorescent complementation (BiFC) exper-
iment. The YN and the YC fragments of YFP were fused to CK2α, CK2β
and ATF4. First of all, we analyzed the expression of the YN-ATF4,
YC-ATF4, YC-CK2α, YN-CK2β, YN-CK2α and YC-CK2β hybrid proteins
by Western blot. As shown in Fig. 3 a, fusion proteins were expressed
and found to migrate at the expected size on a SDS-polyacrylamide
gel. In the next step we transfected HeLa cells with different combina-
tions of the YN-/YC-constructs for testing the interaction between
CK2 and ATF4. As positive control, there was a clear signal for the
interaction of YN-CK2α and YC-CK2β (Fig. 3 b). We found positive
staining after transfection of YC-CK2α and YN-ATF4 fragments. BiFC
signals were obtained exclusively in the nucleus of the transfected
HeLa cells indicating that CK2α bound to ATF4 in the nucleus.
There was no signal for YC-CK2α or YN-ATF4 alone. Although ATF4
was also expressed in combination with CK2β, we never detected
positive signals (data not shown). These results conﬁrmed the
co-immunoprecipitation experiments, demonstrating that ATF4 and
CK2α interact in vivo and in vitro, and this interaction takes place
in the nucleus.
ATF4 is known to be a phosphoprotein [24]. Since most of the
binding partners of CK2 are also substrates of CK2, we asked whether
ATF4 might be also phosphorylated by CK2. Before we started to ana-
lyze the phosphorylation of different truncated forms of ATF4 we ﬁrst
analyzed kinetic parameters of the phosphorylation reaction. ATF4
was incubated with γ[32P]ATP for various times. Phosphorylatedessed and puriﬁed CK2 holoenzyme and GST-tagged ATF4 were incubated together for
12.5% SDS-polyacrylamide gel followed by Western blot. ATF4, CK2α and CK2β were
AG-ATF4. HeLa cells were transfected with p3XFLAG-CMV ATF4 for 24 h. Lysates were
re detected with an anti-FLAG antibody, CK2α with antibody 1A5 and CK2β with anti-
lls were treated with 1 μM thapsigargin for 24 h to induce expression of endogenous
unoprecipitates were detected with antibody #26 against CK2α, CK2β with antibody
ant; SE, sepharose; AB, antibody; molecular markers are indicated on the left part of
Fig. 2. Co-localization of ATF4 and CK2. Immunoﬂuorescence images from HeLa cells treated with MG132 for 24 h. ATF4 was detected with the speciﬁc antibody sc200 and labeled
by Alexa Fluor 488-coupled secondary antibody (green). CK2αwas detected by speciﬁc antibody 1A5 and labeled by Alexa Fluor 546-coupled secondary antibody (red). Overlay of
the images shows co-localization of ATF4 and CK2α (yellow). Scale bars: 50 μm.
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autoradiography (Fig. 4 a). The densitometry of the protein bands
showed that the ATF4 protein was saturated with phosphate after
30 min. We choose this time point to determine the phosphate incor-
poration into ATF4. We performed 3 independent experiments and
determined the incorporation rate to be 0.6±0.2 mol phosphate
into 1 mol of ATF4 (Fig. 4 b), which suggests that not every ATF4 mol-
ecule is phosphorylated.
By a computer based search for CK2 phosphorylation sites with
the consensus sequence S/TXXD/E [39] on the polypeptide chain of
ATF4 (in silico), we identiﬁed 12 putative CK2 sites, which are almost
all localized within the ﬁrst 220 amino acids (Fig. 4 c). In order to nar-
row down the putative CK2 sites we cloned various fragments of the
ATF4 cDNA into a bacterial expression vector. A scheme which repre-
sents the fragments including the respective CK2 sites is shown in
Fig. 4 c. The ATF4 fragments were expressed as fusion proteins withFig. 3. In situ interaction of CK2 with ATF4. a) Hela cells were transfected with the plasmids
24 h. Proteins were separated on a 12.5% SDS-polyacrylamide gel followed by Western
anti-GAPDH antibody as a loading control. Molecular weight markers are indicated at the left
expressing the N- or C-terminal fragments of YFP fused to CK2α, CK2β or ATF4. The compla GST-tag in E. coli, puriﬁed and then used for an in vitro kinase reac-
tion with the CK2 holoenzyme and γ[32P]ATP. Phosphorylated pro-
teins were analyzed on a 12.5% SDS polyacrylamide gel followed by
autoradiography. As a control we also stained the gel with Coomassie
Blue in order to show that we used the same amount of protein
(lower part of Fig. 4 d). Fragment N1, which contains the putative
CK2 sites serine 18, serine 74 and serine 80 was not phosphorylated
by CK2. Thus, these three N-terminal sites can be excluded as CK2
sites. Fragment N2 which represents the ﬁrst 200 amino-terminal
amino acids of ATF4 was also not phosphorylated by CK2, which
excluded also threonine 107, threonine 114, threonine 115, threonine
149, serine 172, serine 184 and threonine 189 as CK2 phosphorylation
sites. On the other hand, three C-terminal fragments of ATF4, namely
C1, ranging from amino acids 94 to 351, C2 ranging from amino acids
173 to 351 and C3 ranging from amino acids 190 to 351 were consid-
erably phosphorylated by CK2. Together with the results obtainedexpressing the N- or C-terminal fragments of YFP fused to ATF4 or CK2α and CK2β for
blot with anti-ATF4 antibody sc200, CK2α and CK2β-speciﬁc antibodies and with
part of the gel. b) Immunoﬂuorescence analysis of HeLa cells transfected with plasmids
emented YFP was detected with anti-GFP antibody. Scale bars: 50 μm.
Fig. 4. Identiﬁcation of the CK2 phosphorylation sites of ATF4. a) Time course study of the phosphorylation of ATF4. ATF4was phosphorylated using the CK2 holoenzyme. After 5, 10, 15, 30 and
45 min the reaction was stopped adding sample buffer. After SDS polyacrylamide gel electrophoresis and autoradiography the bands were subjected to a densitometric analysis. The relative
intensity of the bands at the different time points is shown in the graph. b) Phosphate incorporation rate into the polypeptide chain of ATF4. ATF4was phosphorylatedwith CK2 in the presence
of γ[32P]ATP. Phosphorylated ATF4was analyzed on a SDS polyacrylamide gel. The bandwas excised from the gel and incorporated phosphatewas counted in a scintillation counter. The graph
shows their incorporation of phosphate [mol] into protein [mol] as a result of three independent experiments. c) Schematic representation of N-terminal and C-terminal deletion fragments of
ATF4with the putative CK2phosphorylation sites. d) Phosphorylation of N-terminal andC-terminal deletionmutants of GST-ATF4 by CK2 in vitro kinase assay. The recombinant GST-ATF4 frag-
ments were incubated with or without recombinant CK2 holoenzyme in the presence of kinase buffer and 2 μCi of γ[32P]ATP for 30 min at 37 °C. The samples were separated in a 12.5%
SDS-polyacrylamide gel and the radioactivity was detected by X-ray ﬁlms (upper part). The lower part shows Coomassie Blue staining of the gel. e) The phosphorylation of the recombinant
GST-ATF4, GST-ATF4 T213A and GST-ATF4 S215A proteins were made as described in d). Molecular weight markers are indicated on the left. f) The phosphorylation of recombinant
GST-ATF4 and GST-ATF4 S215A proteins by recombinant CK2α or by recombinant CK2 holoenzyme was made as described in. d) Molecular weight markers are indicated on the left.
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445E. Ampofo et al. / Biochimica et Biophysica Acta 1833 (2013) 439–451with the N-terminal fragments, we have to conclude that serine 215
and threonine 213 are potential phosphorylation sites for CK2.
In the next step we mutated threonine 213 and serine 215 to ala-
nine residues. The alanine mutants were expressed in bacteria and
the puriﬁed proteins were used as substrates for CK2 together with
γ[32P]ATP. As a control, gels were also stained with Coomassie Blue
to demonstrate the protein amount which was used for the phos-
phorylation reaction (lower part of Fig. 4 e). As shown in Fig. 4 e
(upper part), the ATF4 T213A mutant was phosphorylated by CK2
as strong as wild-type ATF4, whereas ATF4 S215A was markedly
less phosphorylated than the two other ATF4 forms. These data
strongly suggest that serine 215 is the main CK2 phosphorylation
site on the polypeptide chain of ATF4.
Most of the CK2 substrates are phosphorylated by the CK2 holoen-
zyme and by CK2α alone. A few substrates are not phosphorylated by
CK2α or CK2α′ but they are efﬁciently phosphorylated by the holoen-
zyme. Finally, a limited number of substrates are not phosphorylated
by the holoenzyme but by the CK2α or CK2α′-subunits (for review
see [40]). Therefore, in the next step we asked to which class of sub-
strates ATF4 might belong. Phosphorylation was performed as above
but with the variation that we used CK2α alone or together with
CK2β. As shown in Fig. 4 f, ATF4 was weakly phosphorylated by
CK2α alone, whereas the holoenzyme consisting of CK2α/CK2β efﬁ-
ciently phosphorylated ATF4. The lower part of Fig. 4 f shows the
gels, stained with Coomassie Blue to demonstrate the protein amount
which was used for the phosphorylation reaction. We made the same
observation when phosphorylating ATF4 with CK2α′-subunit alone
or with a holoenzyme consisting of CK2α′/CK2β (data not shown).
Thus, we have demonstrated that ATF4 is efﬁciently phosphorylated
only by the CK2 holoenzyme.Fig. 5. CK2 interacts with ATF4 S215A in vitro and in vivo. a) Interaction between CK2 and AT
a 12.5% SDS-polyacrylamide gel followed by Western blot where ATF4, CK2α and CK2β we
enous CK2 with FLAG-ATF4 S215A. HeLa cells were transfected with p3XFLAG-CMV ATF4 S
from immunoprecipitates were detected with anti-FLAG antibody, CK2αwith antibody 1A5
SE, sepharose; AB, antibody; molecular weight markers are indicated at the left side of the ge
at 4 °C and then incubated with recombinant CK2 holoenzyme. The bound complexes wereHaving shown that the CK2 holoenzyme bound to ATF4 and that
serine 215 seems to be the major CK2 phosphorylation site, we
asked whether the CK2 phosphorylation of ATF4 might inﬂuence its
binding to CK2. We performed the same experiments as described
above, but instead of wild-type ATF4 we used the S215A mutant. In
a ﬁrst set of experiments we performed a pull-down assay with
GST-tagged ATF4 S215A and CK2 holoenzyme. As shown in Fig. 5 a,
both CK2α and CK2β were co-precipitated with GST-ATF4 S215A. In
another experiment FLAG-tagged ATF4 S215A was transfected into
HeLa cells. FLAG-ATF4 S215A was precipitated with the antibody
sc200 against ATF4. As shown in Fig. 5 b, CK2α was clearly
co-precipitated (IP). Thus, mutant S215A bound to CK2 in vitro and
in vivo. To verify the pull down assay and to compare the binding
capacity of wild-type and mutant ATF4 we used an ELISA based bind-
ing assay as shown in Fig. 5 c. Recombinant CK2 holoenzyme bound to
a microtiter plate was incubated with recombinant GST tagged ATF4
or ATF4 S215A. We found that both ATF4 and ATF4 S215A bound to
CK2 holoenzyme with no signiﬁcant difference. Thus, binding of CK2
to ATF4 is independent of the phosphorylation of ATF4 by CK2.
In the course of our experiments with wild-type ATF4 and the
S215A mutant of ATF4, we always noticed a stronger expression of
mutant ATF4. Therefore, it was an obvious question whether the sta-
bility of ATF4 wild-type and the CK2 phosphorylation mutant ATF4
S215A might be different. After transfection of cells with ATF4 and
ATF4 S215A, protein synthesis was inhibited with cycloheximide.
Cells were harvested immediately after incubation with cyclohexi-
mide (0), after 45 or 90 min incubation and the cell extracts were
analyzed by Western blot with an anti-FLAG antibody. Fig. 6 a
shows that the level of FLAG-ATF4 decreased rapidly whereas
the level of FLAG-ATF4 S215A remained nearly constant over theF4 S215A in vitro as demonstrated by GST pull down assay. Proteins were separated on
re detected using the corresponding antibodies. b) Co-immunoprecipitation of endog-
215A for 24 h. Lysates were incubated with anti-ATF4 antibody sc200. Eluted proteins
and CK2βwith antibody 6D5. C, pre-precipitate; IP, immunoprecipitate; S, supernatant;
ls. c) GST-ATF4 and GST-ATF4 S215A were coated on 96 wells microtiter plates for 16 h
detected as described for the ligand-Western blot assay and visualized with TMB.
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densitometrically scanned and plotted against time (Fig. 6 b). The
half-life of FLAG-ATF4 was around 60 min, which is in the same
range as previously described [24]. In contrast the ATF4 phosphoryla-
tion mutant was signiﬁcantly more stable. To exclude secondaryeffects of cycloheximide on ATF4 and ATF4 S215A, we performed a
pulse-chase labeling experiment with [35S]methionine followed by
immunoprecipitation of ATF4. The labeled and precipitated proteins
were analyzed on a 12.5% SDS-polyacrylamide gel followed by auto-
radiography (Fig. 6 c). Radioactive labeled protein bands were
Fig. 7. Inﬂuence of the CK2 inhibition on endogenous ATF4. HeLa cells were treated
with a) 50 μM TBB or b) 50 μM quinalizarin (Q) for the indicated time period. Control
cells were treated with equal amounts of DMSO (4 h). Cell lysates were prepared and
analyzed on a 12.5% SDS polyacrylamide gel followed by Western blotting using
anti-ATF4 antibody sc-200, anti-GAPDH antibody, anti-α-tubulin antibody and the an-
tibodies anti-eIF2α and anti-p-eIF2α. Molecular weight markers are indicated at left
side of the gels.
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ment we found that FLAG-ATF4 S215A is more stable than
FLAG-ATF4.
In a next step we analyzed the inﬂuence of CK2 phosphorylation
on the expression of endogenous ATF4. For inhibition of CK2 we
used also CK2 dominant negative CK2α and CK2α′ mutants. We
transfected HeLa cells with the dominant negative mutants of CK2α
and CK2α′ to inhibit the CK2 holoenzyme as well as both catalytic
CK2 subunits. First, we determined the CK2 kinase activity after inhi-
bition with the dominant negative mutants. The kinase activity was
reduced by about 40% (Fig. 6 e). Next, we analyzed the protein level
of endogenous ATF4 after transfection of the dominant negative
mutants of CK2α and CK2α′. We found an elevated protein level of
endogenous ATF4 (Fig. 6 f and g). In another approach we used two
speciﬁc and efﬁcient CK2 inhibitors, TBB or quinalizarin (Q) [25,26]
and analyzed accumulation of ATF4 over a time period of 24 h. As
shown in Fig. 7 a, b the level of ATF4 increased transiently between
8 and 12 h after treatment with either of the two CK2 inhibitors. It
was previously shown that inhibition of CK2 kinase activity or silenc-
ing of CK2α induced the ER-stress signaling pathway [41–43]. Within
this pathway the eIF2α kinase, which is phosphorylated and activated
by PERK kinase, is an upstream element of ATF4. This activation of
eIF2α leads to a down-regulation of general protein synthesis where-
as a few proteins including ATF4 are upregulated. Therefore, we
analyzed whether we could detect an upregulation of phosphorylated
(p-eIF2α). Cells were treated as described above with TBB or
quinalizarin. Proteins were analyzed on an SDS polyacrylamide
followed by Western blot with antibodies that detect p-eIF2α or
total eIF2α. As shown in Fig. 7 a and b there is an increase in the phos-
phorylation of eIF2α which goes along with the increase in ATF4.
Thus, the data about the activation of eIF2 are in agreement with
recently published data by Manni et al. Here, we identiﬁed ATF4 as
a down-stream factor of p-eIF2α.
In order to analyze the effect of CK2 on the transcription of ATF4,
we transfected HeLa cells with a luciferase reporter containing the
promoter region of ATF4 in front of the luciferase reporter gene
(Fig. 8 a). Cells were treated with TBB or quinalizarin (Q) and as a
control with DMSO for 24 h to inhibit CK2 activity (Fig. 8 b and c).
After this treatment we detected a strong increase in the luciferase
activity. Thus, we conclude that TBB or quinalizarin treatment of
HeLa cells led to an enhanced transcription of the ATF4 gene which
might also be responsible for a higher ATF4 level. Since we have
already shown an elevated stability of the CK2 phosphorylation
mutant of ATF4, there are obviously two mechanisms contributing
to the elevated ATF4 level; ﬁrst, enhanced transcription of the ATF4
gene and second, elevated stability of ATF4 protein.
It is well known that ATF4 binds to different promoter sequences
and thereby affects the transcription of different genes [44]. We
would like to know whether the CK2 phosphorylation of ATF4 might
inﬂuence its transcription factor activity. We analyzed two different
promoter elements, a sequence from −1850 to +34 in the 5′UTR
from the ATF3 promoter [29] called 5′UTR ATF3-Luc (Fig. 9 a) and a
19 bp long sequence from the CHOP promoter called 2xAARE-Luc [27]
(Fig. 9 c). We detected a reduced transcription activity of FLAG-ATF4
S215A compared to wild-type FLAG-ATF4 by using both elements. The
relative luciferase activity was normalized to the protein amount ofFig. 6. Stability of ATF4. a) HeLa cells were transfected with p3XFLAG-CMV ATF4 and p3XFLAG
cell lysateswere prepared and analyzedbyWestern blotting using anti-FLAG antibody and anti-
time point relative to that of the starting point (untreated) were plotted as a function of time
p3XFLAG-CMV ATF4 and p3XFLAG-CMV ATF4 S215A for 24 h after the cells were incubated in
Cell lysateswere immunoprecipitatedwith anti-ATF4 antibody sc200. The precipitateswere sub
with the Typhoon-Trio imaging system. d) The ratios of the amounts of methionine labeled FLA
plotted as a function of time. e) HeLa cells were transfected with dominant negative mutants o
activitywas determined by the incorporation of [32P]phosphate into the synthetic substrate RRR
control were analyzed byWestern blotting using anti-FLAG antibody, anti-ATF4 antibody (sc20
dominant negative mutants of CK2α and CK2α′ was compared to the amount of empty vectorFLAG-ATF4 and FLAG-ATF4 S215A as detected by Western blot analysis
(Fig. 9 b and d). Thus, we conclude that the CK2 phosphorylation at
serine 215 activates the transcription factor activity of ATF4 in HeLa
cells by using the AARE element of the CHOP promoter or a sequence
from−1850 to +34 in the 5′UTR from the ATF3 promoter.
4. Discussion
Protein kinase CK2 is a ubiquitous, highly pleiotropic protein
kinase which is implicated in the regulation of multiple cellular pro-
cesses [45]. Although CK2 is known for more than 55 years [46] it is
still an enigma how this enzyme regulates so many different process-
es. One key to the understanding of the multiple functions seems to
be its localization in the cell [47]. Targeting CK2 as a holoenzyme
or as individual subunits to a speciﬁc cellular compartment as a
response to various signals and stimuli might be a mechanism for
regulating the phosphorylation of particular substrates. A second
mechanism might be phosphorylation of speciﬁc substrates by the
holoenzyme or by the catalytic α- or α′-subunits. The β-subunit
seems to be responsible for the regulation of the substrate speciﬁcity
of the holoenzyme [40]. Here, we showed that ATF4 is only efﬁciently
phosphorylated by the CK2-holoenzyme and not by the catalytic sub-
units alone. A third mechanism for the regulation of the enzymatic
activity could be the interaction of the holoenzyme or individual sub-
units with proteins or other factors in the cell (for review see: [48]).
Thus, the identiﬁcation of new interacting proteins is an attractive
approach to understand the complex functions of CK2. Using a
yeast-two-hybrid system over the last ten years, a number of different-CMV ATF4 S215A for 24 h. Cells were treated with cycloheximide for the indicated times,
GAPDHantibody. b) The ratios of the amounts of FLAG-ATF4 and FLAG-ATF4 S215A at each
. The diagram shows ﬁve independent experiments c) HeLa cells were transfected with
methionine-free DMEM containing 50 μCi/ml of [35S]methionine for 1 h and then lysed.
jected to SDS polyacrylamide gel electrophoresis andmethionine imagingwas performed
G-ATF4 and FLAG-ATF4 S215A at each time point relative to that of the starting point were
f CK2α and CK2α′ or empty vector (mock) for 24 h. Proteins were extracted and the CK2
DDDSDDD. f) Cell lysates from a) and cell lysates treatedwith andwithout thapsigargin as
0) and anti-α-tubulin antibody. g) The amount of endogenous ATF4 after transfectionwith
transfected cells. The diagram shows four independent experiments.
Fig. 8. Inﬂuence of the CK2 inhibition on ATF4 gene expression. a) Schematic illustration of the ATF4 promoter region in front of the luc reporter gene. HeLa cells were transfected
with a reporter plasmid expressing luciferase under the control of the ATF4 promoter for 24 h. Cells were incubated with fresh medium in the presence of b) quinalizarin (Q) and c)
TBB for 24 h. Control cells were incubated in the presence of equal amounts of DMSO. Cell lysates were prepared and analyzed for luciferase activity. The luciferase activity of the
mock (reporter plasmid expressing luciferase under the control of the ATF4 promoter without treatment) transfected cells was set 100%. The diagram represents 3 independent
experiments.
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ron protein KIF5C [10], the transcription factor Pdx-1 [8], the splice fac-
tor hPrp3p [7], the ribosomal proteins L41 [49], L5 [50], A-raf [51], mos
[52], the Fas-associated protein FAF1 [53], themitochondrial translation
initiation factor 2 [54], propionyl CoA carboxylase β subunit [53] andFig. 9. ATF4 S215A represses promoter activity. a) HeLa cells were transfected with or witho
luciferase under the control of an ATF4 target promoter (5′UTR ATF3-Luc) for 24 h. Cell lys
culated in relation to the corresponding protein amount. c) HeLa cells were transfected wi
expressing luciferase under the control of an ATF4 target promoter (AARE-Luc) for 24 h. Ce
from a) and c) were analyzed by Western blotting using anti-FLAG antibody and anti-GAPD
GAPDH and then to luciferase activity.the pleckstrin homology domain protein CKIP-1 [55] just to mention
but few. These interactions with various cellular proteins strongly sup-
port the idea that CK2 is implicated in many different intracellular pro-
cesses. Here, we present ATF4 as a new binding partner and substrate of
CK2. This interaction was demonstrated by pull-down assays and byut p3XFLAG-CMV ATF4, p3XFLAG-CMV ATF4 S215A and a reporter plasmid expressing
ates were prepared and analyzed for luciferase activity. The luciferase activity was cal-
th or without p3XFLAG-CMV ATF4, p3XFLAG-CMV ATF4 S215A and a reporter plasmid
ll lysates were prepared and analyzed for luciferase activity. b) and d) The cell lysates
H antibody. The relative intensities of FLAG protein contents were normalized ﬁrst to
449E. Ampofo et al. / Biochimica et Biophysica Acta 1833 (2013) 439–451co-immunoprecipitation assays. Both assays showed that ATF4 bound
to CK2α whereas binding to CK2β was found only in the presence of
the CK2 holoenzyme. Thus, one might speculate that CK2β was bound
via its binding to the catalytic CK2α-subunits. This binding was con-
ﬁrmed by two other methods, namely an ELISA based binding assay as
well as bimolecular ﬂuorescent complementation (BiFC) experiments.
These BiFC experiments showed a positive immunoﬂuorescence signal
only in the nucleus indicating that the interaction of CK2 with ATF4 is
restricted to the nucleus.
ATF4 is a key transcriptional effector protein of the cellular stress
response generally known as unfolded protein-response, which is
induced by the accumulation of improperly folded proteins [56]. The
ATF4 pathway is initiated by stress-activated protein kinases, e. g. the
eukaryotic translation initiation factor 2-alpha kinase 3 (PERK), which
phosphorylates eukaryotic translation initiation factor 2 (eIF2α) lead-
ing to a general inhibition of protein synthesis but selective translation
of ATF4 [15]. Recently Manni et al. showed in multiple myeloma cells
that CK2α silencing leads to an induction of the unfolded protein
response (UPR) in the ER which leads to the activation of PERK and
eIF2α (21213). One of the down-stream factors of eIF2α in the UPR is
ATF4whose expressionwas shown here to be upregulated by CK2 inhi-
bition. Thus, with ATF4 we identiﬁed a new factor in the UPR which is
activated by CK2 inhibition. ATF4 is important for cell proliferation, dif-
ferentiation and long-term memory induction [17,57,58]. ATF4 is a
phosphoprotein and it was already shown that it is regulated by phos-
phorylation at multiple sites [24]. It was an obvious question whether
ATF4 is not only a binding partner of CK2 but also a substrate and
whether the phosphorylation has any fundamental consequences for
ATF4. Scanning the polypeptide chain of CK2 for putative CK2 phos-
phorylation sites revealed at least 12 sites. By using ATF4 fragments as
well as by mutation of serine and threonine residues we identiﬁed ser-
ine 215 as themajor CK2 phosphorylation site. Serine 215 is highly con-
served in ATF4 fromXenopus, to rat, mouse and human,which suggests
that this residue is important for the function of ATF4. Serine 215 is in
close vicinity to the recognition motif for β-TrCP, which is the receptor
component of the SCF E3 ubiquitin ligase.β-TrCP co-localizes with ATF4
in the nucleus and controls the stability and subsequently the transcrip-
tional activity of ATF4 [23] as well. Thus, one might speculate that the
CK2 phosphorylation at serine 215 might be also implicated in the reg-
ulation of the stability of ATF4. Working with wild-type ATF4 and the
phosphorylation mutant of ATF4, where serine 215 was replaced by al-
anine, we always noticed a higher level of the phosphorylation mutant
ATF4 protein. This elevated level can be due to a higher stability of the
mutant protein or to an elevated synthesis of ATF4. Here, we showed
that mutation of serine 215 to alanine resulted in an elevated stability
of ATF4. A similar observation was made for serine 219 which repre-
sents a putative CK1 site [24]. Mutation of serine 219 also led to an al-
tered stability of the protein. These data support the idea that the
region around serine 215 and serine 219 is implicated in the regulation
of the stability of ATF4. It has been previously reported that CK2 phos-
phorylation affects also the stability of other proteins. The bcl-2 family
protein Bid is phosphorylated by CK2 which prevents its cleavage by
caspase-8 [59]. The transcription factors max and myc and also PTEN
are stabilized by a CK2 mediated phosphorylation [60–62]. On the
other hand the PML tumor suppressor is phosphorylated by CK2,
which results in an ubiquitin-mediated degradation [63]. Also the von
Hippel Lindau protein VHL is rapidly degraded after CK2 phosphoryla-
tion [64]. These data together with our present data support the idea
that CK2 might also regulate cellular processes by altering the stability
of substrate proteins.
By using the ATF4 promoter we could further demonstrate that
CK2 regulated the transcription of the ATF4 gene. Inhibition of CK2
kinase activity led to an up-regulation of the transcription of ATF4
indicating that the enzymatic activity of CK2 is necessary for the reg-
ulation. Thus, the level of ATF4 seems to be regulated by CK2 by two
different mechanisms; ﬁrst, by the regulation of the transcription ofATF4 and second, by the reduction of the ATF4 stability after CK2
phosphorylation at serine 215. Recently Schneider et al. also pub-
lished an increase in the level of ATF4 after treatment of prostate can-
cer cells with CK2 inhibitors [43]. However, in these cells the elevated
level of ATF4 was achieved without an upregulation of the transcrip-
tion of ATF4. Furthermore, in this study it was shown that ATF4 is
responsible for the transactivation of CHOP, which was earlier
shown to be responsible for apoptosis induction in this particular
prostate cancer cell [42]. A dominant negative mutant of ATF4
inactivated the transcriptional factor activity of ATF4 with respect to
CHOP expression. The CK2 phosphorylation mutant of ATF4 exhibits
the same effect demonstrating that the phosphorylation at serine
215 is required for the transcription factor activity of ATF4. As a tran-
scriptional activator ATF4 regulates not only the expression of CHOP
[66] but also the expression of RANKL (a receptor of nuclear
factor-κB ligand) [65], osteocalcin [66], GADD34 [67], the adenoviral
E1a inducible gene E4 [68] and several other genes involved in the
cellular redox system, amino acid metabolism, mitochondrial func-
tion [14] and differentiation including ATF3. The phosphorylation of
ATF4 by CK2 seems to be a major role in the transcriptional regulation
of down-stream factors such as ATF3 and CHOP. ATF3 is induced in
response to endoplasmic reticulum (ER) stress or amino acid starva-
tion by ATF4 [69] and also contributes to the induction of CHOP.
Here, we show that mutant ATF4 S215A showed a reduced transcrip-
tional activity for the CHOP 2xAARE promoter and the ATF3 promoter.
So we conclude that the CK2 protein kinase activity and phosphoryla-
tion of ATF4 by CK2 regulate the transcription factor activity of ATF4.
Our present data ﬁt perfectly into the gap which was left over by the
work of Manni et al. showing the activation of up-stream factors of
ATF4 [41] and Schneider et al. [43], demonstrating the activation of
down-stream factors of ATF4 in the UPR signaling pathway.
In addition to ATF4, CHOP and other members of the stress acti-
vated cellular pathway, such as Nrf-2, are substrates for protein
kinase CK2. CK2 phosphorylation of Nrf-2 is necessary for the shut-
tling of Nrf-2 from the cytoplasm to the nucleus [21]. Phosphorylation
of CHOP by CK2 leads to down-regulation of the CHOP transcription
factor activity. With the identiﬁcation of ATF4 as a further factor in
this signaling pathway whose stability and transcription factor activ-
ity are directly regulated by CK2, we could further demonstrate the
important role of CK2 in the ER-stress-signaling pathway.References
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